EMA reviews GSK's new Shingrix syringe for shingles prevention
LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...
GlobalData on MSN2d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.
Daily2d
GSK Shingrix new prefilled syringe presentation accepted for review by EMA
London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of ...
Pharmabiz1d
EMA accepts for review regulatory application of GSK’s Shingrix new prefilled syringe presentation for prevention of shingles
EMA accepts for review regulatory application of GSK’s Shingrix new prefilled syringe presentation for prevention of shingles: London, UK Wednesday, January 29, 2025, 13:00 Hrs ...
GSK announces EMA to review the regulatory application of Shingrix
GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...
FierceBiotech7d
GSK, Merck and Pfizer in Ab&B's sights as Chinese vaccine biotech files for IPO
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...
PharmiWeb3d
GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...
GSK's pre-filled shingles vaccine accepted for review by EMA
GSK has announced that a pre-filled syringe version of its Shingrix shingles vaccine has been accepted for review by the ...
EuropaWire3d
GSK Announces EMA Review of Prefilled Syringe Presentation for Shingrix Vaccine
GSK has announced that the European Medicines Agency (EMA) has accepted its regulatory application for a prefilled syringe presentation of Shingrix ...
London South East3d
EMA accept review Shingrix syringe presentation
GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK's Recombinant Zoster Vaccine ...
PharmiWeb3d
GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
6 About Shingrix (Recombinant Zoster Vaccine or RZV) Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) is a non-live, recombinant subunit vaccine indicated for the prevention of shingles in adults 50 ...